BCL2 and Miyoshi myopathy: Patients with relapsed MM showed an increased expression of BCLXL; therefore, in cases of resistance to BCL2 inhibition with venetoclax, a combination of BCL2 and BCLXL inhibitors presents an effective alternative, indicating that BCLXL dependence is also a pro-survival factor in MM [51].